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ABSTRACT
Purpose: Pulmonary embolism (PE) has a significant associated morbidity and mortality. The role of diagnostic imaging in 
PE is being increasingly undertaken by computed tomography pulmonary angiography (CTPA). An advantage of CTPA is its 
ability to simultaneously provide information on the lung parenchyma, mediastinum, pleural spaces, and chest wall. A sample 
of CTPAs was therefore reviewed to identify the types of additional pathology demonstrated.
Materials and Methods: One hundred and ninety-eight CTPA examinations were retrospectively reviewed. A record was made 
of the presence of PE and any additional pathology, with particular interest given to “incidental” pathology, or pathology that 
was unsuspected but which was significant enough to change the patient’s management. A note was also made as to the adequacy 
of the study. D-Dimer values were recorded when available.
Results: PE was demonstrated in 56 studies (28.3%). Additional pathology was seen in 112 studies (56.6%), of which 17 were 
categorised as incidental. These included multiple pulmonary nodules, solitary lung lesions, destructive bony lesions, pancreatitis, 
a solid renal mass, mesothelioma, reactivated pulmonary tuberculosis, recurrent bronchial carcinoma, pulmonary fibrosis, an 
SVC filling defect, and a compression fracture of T10.
Conclusion: The prevalence of PE in our sample was 28.3%, compared with a reported prevalence, mainly by pulmonary 
angiography, of between 19% and 79%. Secondary findings were found in 56.6% of scans, with completely incidental findings 
demonstrated in 17 patients (9%). This emphasizes the usefulness of CTPA in providing additional diagnostic information and 
alternative diagnoses in patients with suspected PE.
INTRODUCTION
Pulmonary embolism (PE) is a condition with a significant 
associated morbidity and mortality. The incidence of PE has 
been estimated at between 300,000 and 600,000 episodes 
per year in the US, with between 50,000 and 200,000 deaths 
occurring as a result1,2. When the diagnosis is confirmed and 
treatment promptly initiated, the incidence of recurrence is 
reduced and death is infrequent.
The diagnosis of PE is fraught with difficulty. The presenting 
symptoms are non-specific and inconsistently present3. The 
clinical  presentation  may  also  be  atypical  or  be  masked 
by other coexistent disease. The use of a negative serum 
D-Dimer estimation combined with a low clinical probability 
score allows for identification of patients at low risk and in 
whom a diagnosis of PE can be excluded before imaging is 
required4.
The  role  of  imaging  in  the  diagnosis  of  PE  is  being 
increasingly undertaken by computed tomography pulmonary 
angiography (CTPA), which can demonstrate filling defects 
in  segmental  and  subsegmental  pulmonary  arteries5,6. 
The  advent  of  multidetector-row  CT  (MDCT)  allows  for 
shorter image acquisition times and narrower collimation, 
facilitating isotropic data acquisition and reducing patient 
movement artefact. Multidetector-row CTPA has been shown 
to have a sensitivity of 100% and a specificity of 89% in 
the investigation of patients with suspected PE, equivalent 
to or possibly higher than that of conventional pulmonary 
angiography7. CTPA is now included in guidelines for the 
management of PE in both the United Kingdom and United 
States of America, and patients with a good quality negative 
CTPA do not require further investigation or treatment for 
PE8,9. It should be noted, however, that a number of factors 
can affect whether or not a CTPA is of good quality. These 
include issues relating to the patient, such as the ability to 
breath-hold  during  the  study,  and  anatomical  issues  such 
as patient size, which may have a bearing on the signal to 
noise ratio of the acquired images. Technical problems can 
also reduce the quality of the study, and these might include 
issues relating to intravenous (IV) access, and to the timing 
of image acquisition, both of which could have a bearing on 
the opacification of the pulmonary arteries.
One of the advantages of CT over other imaging modalities 
is its ability to concurrently present information on the lung © The Ulster Medical Society, 2008.
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Ta b l e  I. 
Other diagnoses commonly found.
Diagnosis Frequency
Consolidation 45
Pleural Effusion 35
Chronic Bronchitis and Emphysema 13
Multiple Nodules 10
Lymphadenopathy 7
Cardiomegaly 6
Solitary Pulmonary Nodule 5
Bronchiectasis 4
Pulmonary Oedema 3
Fig 1b. Lung nodule seen posteriorly in the right lower lobe.
Fig 1c. In this patient the lung metastases were from a known 
hepatocellular carcinoma, seen as a rather diffuse abnormally 
enhancing mass within the liver.
Fig 2a. Lung nodule identified in the apical segment of the right 
lower lobe.
Fig 2b. Mediastinal lymphadenopathy in the subcarinal region of 
the same patient.
Fig 1a. Lung nodule demonstrated posteriorly in the left upper 
lobe.© The Ulster Medical Society, 2008.
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parenchyma, mediastinum and pleural spaces, in addition to 
that provided on the pulmonary arteries. Therefore, part of the 
interpretation process includes assessment of these structures, 
as well as the visible bony skeleton and upper abdomen, to 
identify other pathologies which may be associated with PE 
or which may be incidental. For these reasons, a sample of 
CTPAs was reviewed to identify what types of additional 
pathology are identified and how frequently, in the setting of 
CTPA examinations for suspected PE.
METHODOLOGY
One  hundred  and  ninety-eight  CTPA  examinations  were 
retrospectively  reviewed.  These  were  performed  between 
January and November 2006, at the Ulster Hospital, a district 
general  hospital  on  the  outskirts  of  Belfast,  in  Northern 
Ireland.  The  scanner  used  was  a 
16-slice  Philips  MX  8000  IDT 
16 channel scanner. A record was 
made as to whether or not a PE was 
demonstrated and if any additional 
pathology was identified. A note was 
also made as to the adequacy of the 
study, and what factors contributed 
to an inadequate study. A D-Dimer 
value  was  noted  if  it  had  been 
available  (normal  range  less  than 
250 nanograms per millilitre).
Any  additional  pathology 
demonstrated  was  recorded, 
with  particular  interest  given  to 
“incidental” pathology, or pathology 
that  was  completely  unsuspected 
but  which  was  significant  enough 
to require a change in the patient’s 
management. Significant pathology, 
which was already known about, such 
as known metastatic lung disease, 
was  noted  but  not  categorised  as 
incidental.
RESULTS
Of the 198 examinations performed, 
PE was demonstrated in 56 (28.3%). 
Other  pathology  was  seen  in  112 
studies  (56.6%),  with  the  more 
common  findings  listed  in  table 
I.  These  included  consolidation 
(n=45),  pleural  effusion  (n=35), 
changes  consistent  with  chronic 
obstructive  pulmonary  disease  (COPD)  (n=13),  multiple 
pulmonary  nodules  (n=10),  lymphadenopathy  (n=7), 
cardiomegaly  (n=6),  solitary  pulmonary  nodules  (n=5), 
bronchiectasis (n=4), and pulmonary oedema (n=3).
Seventeen findings categorised as incidental were demonstrated 
(8.6%). These are listed in table II.
One hundred and forty-seven patients had serum D-Dimer 
estimation performed during the admission in which they 
underwent CTPA. Results between 250 and 1000 were given 
a numerical value, with the remaining results given as “less 
than 250” or “greater than 1000”. None of the patients with a 
D-Dimer of less than 250 had a PE demonstrated on CTPA. 
PE was demonstrated in 31 of the 72 patients with a D-Dimer 
of greater than 1000 (43.1%). PE was demonstrated in 13 
of the 64 patients whose D-Dimer levels were between 250 
and 1000. A student’s t-test showed that difference between 
the D-Dimers for the PE and No PE groups, when they fell 
between 250 and 1000, was not statistically significant (P 
value 0.14).
Forty-nine scans (24.7%) were reported as at least technically 
adequate. A  total  of  36  scans  (18.2%)  were  reported  as 
suboptimal  or  inadequate,  with  the  stated  reasons,  listed 
in table III, including patient movement (n=15), technical 
problems (n=14), patient body habitus (n=6), problems with 
IV  access  (n=2),  or  poor  opacification  of  the  pulmonary 
Ta b l e  II. 
Summary of findings categorised as incidental.
Incidental findings No. of 
patients
Presumptive diagnosis
Multiple pulmonary nodules 4 Multiple metastases n = 3    (fig 1)
Inflammatory nodules n = 1 (fig 2)
Solitary lung lesions 4 Bronchial carcinoma n = 4   (fig 3)
Destructive bony lesions and 
spiculated lung mass
1 Bony metastases (fig 4a) 
with primary lung carcinoma (fig 4b)
Peritoneal inflammatory disease 1 Pancreatitis, confirmed with 
additional scan range (fig 5)
Solid renal mass 1 Renal cell carcinoma (fig 6)
Nodular pleural thickening 1 Mesothelioma (fig 7)
Apical fibrosis, cyst formation 
and air fluid levels
1 Reactivated TB (fig 8)
Previous left pneumonectomy, 
right lung mass
1 Tumour recurrence (fig 9)
Prominent interstitial lung 
markings and cyst formation
Filling defect right atrium and 
superior vena cava
Compression fracture 10th 
thoracic vertebral body
1
1
1
Interstitial lung disease (fig 10)
Confirmed by echocardiogram, 
patient died before diagnosis 
confirmed (fig 11)
Osteoporotic collapse (image not 
available)
Ta b l e  III.
Reasons for limited adequacy of scan.
Reason Number of 
Scans
Patient Movement 15
Technical Reasons 14
Patient Body Habitus 6
IV Access Problems 
Valsalva manoeuvre
2
2© The Ulster Medical Society, 2008.
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arteries due to the patient performing the Valsalva manoeuvre 
during image acquisition, thereby reducing systemic venous 
return  (n=2).  No  comment  was  made  on  the  technical 
adequacy of the study in 112 patients (56%). 
CONCLUSIONS
The prevalence of PE, as demonstrated by CTPA, in our 
reviewed  sample  was  28.3%,  compared  with  a  reported 
prevalence,  demonstrated  in  the  majority  by  pulmonary 
angiography, ranging between 19% and 79%10. Secondary 
findings  were  found  in  56.6%  of  scans,  highlighting  the 
usefulness of CTPA in providing more thorough information 
in the majority of patients, as well as demonstrating pathology 
that was unsuspected or which required further individual 
management in 17 patients (9%).
A negative D-Dimer result, categorised as less than 250 in our 
institution, correlated with a negative CTPA in the 7 patients 
Fig 3.  A spiculated mass is shown in the right upper lobe. Fig 5a. Upper abdominal organs visible on the CTPA scan range 
demonstrate stranding of the peripancreatic fat with fluid in the 
left paracolic gutter, suggestive of pancreatitis.
Fig 4a. A destructive lesion of the posteromedial aspect of the 
right rib is present.
Fig 5b. An oblique coronal reformat from an additional upper 
abdominal range performed immediately after the CTPA 
demonstrated peripancreatic inflammation consistent with 
pancreatits.
Fig 4b. Lung window settings in the same patient demonstrates a 
spiculated mass in the left lower lobe.© The Ulster Medical Society, 2008.
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in which it occurred, which confirms its use combined with 
clinical scoring as a useful pre-imaging tool to assign risk. 
Although the numbers in this review are too small to assign 
significance to a negative D-Dimer, they are in concordance 
with the known high negative predictive value of this test11. 
When greater than 250, the absolute D-Dimer level does not 
appear to be helpful, as pulmonary emboli were seen with 
relatively low titres (371 being the lowest in this sample), and 
high titres (greater than 1000) were seen in patients with no 
PE demonstrated by CTPA. The lower titres seen may reflect 
the timing of D-Dimer estimation in relation to the onset of 
symptoms, as D-Dimer estimation may have taken place after 
the blood levels had “peaked”.
It is clear that a good CTPA study is dependent on a number 
of technical factors, including the parameters used for image 
acquisition  and  the  adequacy  of  the  opacification  of  the 
pulmonary arteries, which itself is dependent on a number of 
factors. In reviewing our reports, no mention of the adequacy 
of the examination was made in the majority (56.6%), a figure 
which could be significantly improved upon. If the scan was 
reported as being of limited adequacy, a reason was generally 
given in the report.
Fig 6. Additional upper abdominal scan range demonstrates a left-
sided solid renal lesion.
Fig 9. Fluid-filled left thoracic cavity in keeping with a left 
pneumonectomy. A right-sided mass lesion is seen.
Fig 10. Bilateral apical interstitial fibrosis and cyst formation.
Fig 8. Right upper lobe fibrosis and cystic change with air/fluid 
levels.
Fig 7. Coronal reformat image of the lungs showing nodular 
circumferential pleural thickening.© The Ulster Medical Society, 2008.
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Shah H, et al. Suspected acute pulmonary embolism: evaluation with 
multi-detector row ct versus digital subtraction pulmonary arteriography. 
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American College of Emergency Physicians Clinical Policies Committee;  9. 
Clinical Policies Committee Subcommittee on Suspected Pulmonary 
Embolism.  Clinical  policy:  critical  issues  in  the  evaluation  and 
management of adult patients presenting with suspected pulmonary 
embolism. Ann Emerg Med 2003;41(6):257-70.
Hogg K, Brown G, Dunning J, Wright J, Carley S, Foex B, Mackway-Jones  10. 
K. Diagnosis of pulmonary embolism with CT pulmonary angiography: 
a systematic review. Emerg Med J 2006;23(3):172-8.
In highlighting the value of CTPA, not only in the detection 
of PE, but in providing information on other concurrent chest 
and  occasionally  upper  abdominal  pathology,  our  review 
demonstrates that careful evaluation of the other visualised 
structures,  including  the  lung  parenchyma,  mediastinal 
structures, bony skeleton and visualised upper abdominal 
structures, is necessary to provide a comprehensive assessment 
of the study and may provide information to the clinician 
about processes that were not suspected and which may need 
action that would not otherwise have been effected.
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